The landscape of copy number variations in Finnish families with autism spectrum disorders

Autism Research

Volumn 9, Issue 1, 2016, Pages 9-16

  Kanduri, Chakravarthi ^a   Kantojärvi, Katri ^a   Salo, Paula M ^a   Vanhala, Raija ^a   Buck, Gemma ^b   Blancher, Christine ^b   Lähdesmäki, Harri ^c   Järvelä, Irma ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c AALTO UNIVERSITY   (Finland)

Author keywords

Autism spectrum disorders; Copy number variations; Finnish population; Genome wide SNP arrays

Indexed keywords

BRADYKININ RECEPTOR; CAFFEINE; OXIDOREDUCTASE; RETINOL;

AP2M1 GENE; ARTICLE; ASPERGER SYNDROME; AUTISM; BDKRB1 GENE; BDKRB2 GENE; CALCIUM SIGNALING; CASE CONTROL STUDY; CHRNA7 GENE; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME 22Q; COL11A2 GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; CYP2E1 GENE; DISC1 GENE; DRUG METABOLISM; ENDODERM; EXON; F2RL1 GENE; FEMALE; FHIT GENE; FINN (PEOPLE); GENETIC RISK; GSTM1 GENE; GSTM2 GENE; GSTM3 GENE; GSTM4 GENE; GSTM5 GENE; HUMAN; LILRB3 GENE; MAJOR CLINICAL STUDY; MALE; METABOLISM; PLCD3 GENE; PRIORITY JOURNAL; PTH1R GENE; RBFOX1 GENE; RPS9 GENE; SPTA1 GENE; UQCRC2 GENE; FINLAND; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTISM SPECTRUM DISORDER; CASE-CONTROL STUDIES; DNA COPY NUMBER VARIATIONS; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84956680255     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1502     Document Type: Article

References (73)

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders, Fourth edition. American Psychiatric Association. 943p.
2. Auranen, M., Vanhala, R., Varilo, T., Ayers, K., Kempas, E., Ylisaukko-Oja, T., Järvelä, I. (2002). A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. American Journal of Human Genetics, 71, 777-790. doi:10.1086/342720
3. Backes, C., Keller, A., Kuentzer, J., Kneissl, B., Comtesse, N., Elnakady, Y. A., Lenhof, H. P. (2007). GeneTrail-advanced gene set enrichment analysis. Nucleic Acids Research, 35(Web Server issue), W186-92. doi:10.1093/nar/gkm323
4. Bading, H., Ginty, D. D., & Greenberg, M. E. (1993). Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science, 260, 181-186. doi:8097060
5. Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nature Reviews. Genetics, 12, 56-68. doi:10.1038/nrg2918
6. Betancur, C. (2011). Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Research, 1380, 42-77. doi:10.1016/j.brainres.2010.11.078
7. Buyske, S., Williams, T. A., Mars, A. E., Stenroos, E. S., Ming, S. X., Wang, R., Johnson, W. G. (2006). Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genetics, 7, 8. doi:10.1186/1471-2156-7-8
8. Carter, M. T., & Scherer, S. W. (2013). Autism spectrum disorder in the genetics clinic: a review. Clinical Genetics, 83, 399-407. doi:10.1111/cge.12101
9. Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Cook, E. H. (2008). Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biological Psychiatry, 63, 1111-1117. doi:10.1016/j.biopsych.2008.01.009
10. Colella, S., Yau, C., Taylor, J. M., Mirza, G., Butler, H., Clouston, P., Ragoussis, J. (2007). QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Research, 35(6), 2013-2025. doi:10.1093/nar/gkm076
11. Devlin, B., & Scherer, S. W. (2012). Genetic architecture in autism spectrum disorder. Current Opinion in Genetics & Development, 22, 229-237. doi:10.1016/j.gde.2012.03.002
12. Ebert, D. H., & Greenberg, M. E. (2013). Activity-dependent neuronal signalling and autism spectrum disorder. Nature, 493, 327-37. doi:10.1038/nature11860
13. Ehlers, S., & Gillberg, C. (1993). The epidemiology of Asperger syndrome. A total population study. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 34, 1327-1350.
14. Fogel, B. L., Wexler, E., Wahnich, A., Friedrich, T., Vijayendran, C., Gao, F.,. Geschwind, D. H. (2012). RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Human Molecular Genetics, 21, 4171-86. doi:10.1093/hmg/dds240
15. Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simono vic, M., Roth, A., Jensen, L. J. (2013). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Research, 41, D808-15. doi:10.1093/nar/gks1094
16. Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Dalla Bernardina, B., & Bonassi, S. (2012). Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses. Free Radical Biology and Medicine, 52, 2128-2141. doi:10.1016/j.freeradbiomed.2012.03.011
17. Gargus, J. J. (2009). Genetic calcium signaling abnormalities in the central nervous system: seizures, migraine, and autism. Annals of the New York Academy of Sciences, 1151, 133-156. doi:10.1111/j.1749-6632.2008.03572.x
18. Gehman, L. T., Stoilov, P., Maguire, J., Damianov, A., Lin, C.-H., Shiue, L., Black, D. L. (2011). The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nature Genetics, 43, 706-711. doi:10.1038/ng.841
19. Ghanizadeh, A., Akhondzadeh, S., Hormozi, M., Makarem, A., Abotorabi-Zarchi, M., & Firoozabadi, A. (2012). Glutathione-Related Factors and Oxidative Stress in Autism, A Review. Current Medicinal Chemistry, 19, 4000-4005. doi:10.2174/092986712802002572
20. Gilman, S. R., Iossifov, I., Levy, D., Ronemus, M., Wigler, M., & Vitkup, D. (2011). Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron, 70, 898-907. doi:10.1016/j.neuron.2011.05.021
21. Girirajan, S., Dennis, M. Y., Baker, C., Malig, M., Coe, B. P., Campbell, C. D.,. Eichler, E. E. (2013). Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder. American Journal of Human Genetics, 92, 221-37. doi:10.1016/j.ajhg.2012.12.016
22. Girirajan, S., Johnson, R. L., Tassone, F., Balciuniene, J., Katiyar, N., Fox, K., Selleck, S. B. (2013). Global increases in both common and rare copy number load associated with autism. Human Molecular Genetics, 22, 2870-80. doi:10.1093/hmg/ddt136
23. Griswold, A. J., Ma, D., Cukier, H. N., Nations, L. D., Schmidt, M. aA., Chung, R.-H., Pericak-Vance, M. a. (2012). Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Human Molecular Genetics, 21, 3513-23. doi:10.1093/hmg/dds164
24. Jacquemont, M.-L., Sanlaville, D., Redon, R., Raoul, O., Cormier-Daire, V., Lyonnet, S., Philippe, A. (2006). Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. Journal of Medical Genetics, 43, 843-849. doi:10.1136/jmg.2006.043166
25. James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S., Pavliv, O., & Gaylor, D. W. (2009). Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J, 23(8), 2374-2383. doi:10.1096/fj.08-128926
26. Kanduri, C., Ukkola-Vuoti, L., Oikkonen, J., Buck, G., Blancher, C., Raijas, P., Karma, K., Lähdesmäki, H., Järvelä, I. (2013). The genome-wide landscape of copy number variations in the MUSGEN study provides evidence for a founder effect in the isolated Finnish population. European Journal of Human Genetics EJHG, 21, 1411-1416. doi:10.1038/ejhg.2013.60
27. Kilpinen, H., Ylisaukko-Oja, T., Hennah, W., Palo, O. M., Varilo, T., Vanhala, R., Peltonen, L. (2008). Association of DISC1 with autism and Asperger syndrome. Molecular Psychiatry, 13, 187-196. doi:10.1038/sj.mp.4002031
28. Kim, J. Y., Liu, C. Y., Zhang, F., Duan, X., Wen, Z., Song, J., Ming, G. (2012). Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia. Cell, 148, 1051-1064. doi:10.1016/j.cell.2011.12.037
29. Kristiansson, K., Perola, M., Tikkanen, E., Kettunen, J., Surakka, I., Havulinna, A. S., Salomaa, V. (2012). Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits. Circulation: Cardiovascular Genetics, 5, 242-249. doi:10.1161/CIRCGENETICS.111.961482
30. Krumm, N., O'Roak, B. J., Karakoc, E., Mohajeri, K., Nelson, B., Vives, L., Eichler, E. E. (2013). Transmission Disequilibrium of Small CNVs in Simplex Autism. American Journal of Human Genetics, 93, 595-606. doi:10.1016/j.ajhg.2013.07.024
31. Kurian, S. M., Le-Niculescu, H., Patel, S. D., Bertram, D., Davis, J., Dike, C., Niculescu, A. B. (2011). Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry, 16(1), 37-58. doi:10.1038/mp.2009.117
32. Le-Niculescu, H., Balaraman, Y., Patel, S. D., Ayalew, M., Gupta, J., Kuczenski, R., Niculescu, A. B. (2011). Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Translational Psychiatry, 1, e9, doi:10.1038/tp.2011.9
33. Le-Niculescu, H., Kurian, S. M., Yehyawi, N., Dike, C., Patel, S. D., Edenberg, H. J., Niculescu, A. B. (2009). Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry, 14(2), 156-174. doi:10.1038/mp.2008.11
34. Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Bourgeron, T. (2012). Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genetics, 8, e1002521. doi:10.1371/journal.pgen.1002521
35. Levy, D., Ronemus, M., Yamrom, B., Lee, Y., Leotta, A., Kendall, J., Wigler, M. (2011). Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron, 70, 886-897. doi:10.1016/j.neuron.2011.05.015
36. Macdonald, J. R., Ziman, R., Yuen, R. K. C., Feuk, L., & Scherer, S. W. (2014). The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Research, 42, D986-992. doi:10.1093/nar/gkt958
37. Malhotra, D., & Sebat, J. (2012). CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics. Cell, 148, 1223-1241. doi:10.1016/j.cell.2012.02.039
38. Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Scherer, S. W. (2008). Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics, 82, 477-488. doi:10.1016/j.ajhg.2007.12.009
39. Morbidity and Mortal Weekly Report. (2012). Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network. Autism and Developmental Disabilities Monitoring (ADDM) Network, 61, 1-44. Retrieved from www.cdc.gov/ncbddd/autism/documents/ADDM-2012-Community-Report.pdf
40. Neale, B. M., Kou, Y., Liu, L., Ma'ayan, A., Samocha, K. E., Sabo, A., Daly, M. J. (2012). Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485, 242-245. doi:10.1038/nature11011
41. Niculescu, A. B. (2013). Convergent functional genomics of psychiatric disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 162B, 587-594. doi:10.1002/ajmg.b.32163
42. Norio, R. (2003). Finnish disease heritage II: population prehistory and genetic roots of Finns. Human Genetics, 112(5-6), 457-469. doi:10.1007/s00439-002-0876-2
43. O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., Eichler, E. E. (2011). Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genetics, 43, 585-589. doi:10.1038/ng0412-471
44. O'Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Eichler, E. E. (2012). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature, 485, 246-250. doi:10.1038/nature10989
45. Peltonen, L., Jalanko, A., & Varilo, T. (1999). Molecular genetics of the Finnish disease heritage. Human Molecular Genetics, 8(10), 1913-1923.
46. Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., Lönnqvist, J. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64, 19-28. doi:10.1001/archpsyc.64.1.19
47. Perlmann, T. (2002). Retinoid metabolism: a balancing act. Nature Genetics, 31(1), 7-8. doi:10.1038/ng877
48. Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Betancur, C. (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466, 368-372. doi:10.1038/nature09146
49. Pirkola, S. P., Isometsä, E., Suvisaari, J., Aro, H., Joukamaa, M., Poikolainen, K., Lönnqvist, J. K. (2005). DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-results from the Health 2000 Study. Social Psychiatry and Psychiatric Epidemiology, 40, 1-10. doi:10.1007/s00127-005-0848-7
50. Poultney, C. S., Goldberg, A. P., Drapeau, E., Kou, Y., Harony-Nicolas, H., Kajiwara, Y., Buxbaum, J. D. (2013). Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. American Journal of Human Genetics, 93, 607-19. doi:10.1016/j.ajhg.2013.09.001
51. Prasad, A., Merico, D., Thiruvahindrapuram, B., Wei, J., Lionel, A. C., Sato, D., Scherer, S. W. (2012). A discovery resource of rare copy number variations in individuals with autism spectrum disorder. G3 (Bethesda, Md.), 2, 1665-85. doi:10.1534/g3.112.004689
52. Raychaudhuri, S., Korn, J. M., McCarroll, S. A., Altshuler, D., Sklar, P., Purcell, S., & Daly, M. J. (2010). Accurately assessing the risk of schizophrenia conferred by rare copy-number variation affecting genes with brain function. PLoS Genetics, 6, e1001097. doi:10.1371/journal.pgen.1001097
53. Reese, S. E., Archer, K. J., Therneau, T. M., Atkinson, E. J., Vachon, C. M., de Andrade, M., Eckel-Passow, J. E. (2013). A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics (Oxford, England), 29, 2877-83. doi:10.1093/bioinformatics/btt480
54. Rose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., & James, S. J. (2012). Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Translational Psychiatry, 2, e134. doi:10.1038/tp.2012.61
55. Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., State, M. W. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron, 70(5), 863-885. doi:S0896-6273(11)00374-6 [pii] 10.1016/j.neuron.2011.05.002
56. Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., State, M. W. (2012). De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature, 485, 237-241. doi:10.1038/nature10945
57. Scherer, S. W., & Dawson, G. (2011). Risk factors for autism: translating genomic discoveries into diagnostics. Human Genetics, 130, 123-148. doi:10.1007/s00439-011-1037-2
58. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Wigler, M. (2007). Strong association of de novo copy number mutations with autism. Science, 316(5823), 445-449. doi:10.1126/science.1138659
59. Serajee, F. J., Nabi, R., Zhong, H., & Huq, M. (2004). Polymorphisms in xenobiotic metabolism genes and autism. Journal of Child Neurology, 19(6), 413-417. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15446388
60. Singh, K. K., De Rienzo, G., Drane, L., Mao, Y., Flood, Z., Madison, J., Tsai, L.-H. (2011). Common DISC1 polymorphisms disrupt Wnt/GSK3β signaling and brain development. Neuron, 72, 545-558. doi:10.1016/j.neuron.2011.09.030
61. State, M. W., & Levitt, P. (2011). The conundrums of understanding genetic risks for autism spectrum disorders. Nature Neuroscience, 14, 1499-1506. doi:10.1038/nn.2924
62. Stone, J. L., O'Donovan, M. C., Gurling, H., Kirov, G. K., Blackwood, D. H. R., Corvin, A., Ardlie, K. (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature, 455, 237-241. doi:10.1038/nature07239
63. Stutzmann, G. E. (2005). Calcium dysregulation, IP3 signaling, and Alzheimer's disease. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 11, 110-115. doi:10.1177/1073858404270899
64. Szatmari, P., Paterson, A. D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.-Q., Meyer, K. J. (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics, 39, 319-328. doi:10.1038/ng1985
65. Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Sebat, J. (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science, 320(5875), 539-543. doi: 10.1126/science.1155174
66. Wang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S. F., Bucan, M. (2007). PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Research, 17(11), 1665-1674. doi: 10.1101/gr.6861907
67. Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Hakonarson, H. (2009). Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature, 459, 528-533. doi:10.1038/nature07999
68. Weiss, L. A., Arking, D. E., Daly, M. J., & Chakravarti, A. (2009). A genome-wide linkage and association scan reveals novel loci for autism. Nature, 461, 802-808. doi:10.1038/nature08490
69. Williams, N. M., Zaharieva, I., Martin, A., Langley, K., Mantripragada, K., Fossdal, R., Thapar, A. (2010). Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis. Lancet, 376, 1401-1408. doi:10.1016/S0140-6736(10)61109-9
70. World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders. International Classification, 10, 1-267. doi:10.1002/1520-6505(2000)9:5<201::AID-EVAN2>3.3.CO;2-P
71. Wu, G., Fang, Y. Z., Yang, S., Lupton, J. R., & Turner, N. D. (2004). Glutathione metabolism and its implications for health. Journal of Nutrition, 134(3), 489-492. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14988435
72. Xu, L.-M., Li, J.-R., Huang, Y., Zhao, M., Tang, X., & Wei, L. (2012). AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Research, 40, D1016-22. doi:10.1093/nar/gkr1145
73. Yu, W., Gwinn, M., Clyne, M., Yesupriya, A., & Khoury, M. J. (2008). A navigator for human genome epidemiology. Nature Genetics, 40, 124-125. doi:10.1038/ng0208-124